Immunosuppressive CD14(+)HLA-DR(lo/neg) monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes

Immunological strategies to treat pancreatic cancer offer new therapeutic approaches to improve patient outcomes. Understanding alterations in the immune systems of pancreatic cancer patients will likely lead to advances in immunotherapy for the disease. We profiled peripheral blood leukocytes from...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Javeed, Naureen, Gustafson, Michael P., Dutta, Shamit K., Lin, Yi, Bamlet, William R., Oberg, Ann L., Petersen, Gloria M., Chari, Suresh T., Dietz, Allan B., Mukhopadhyay, Debabrata
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283619/
https://ncbi.nlm.nih.gov/pubmed/28197368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1252013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia